Go back

Experts call for Australian mission on RNA innovation

   

National “roundtable” meeting calls for RNA development capacity and clinical trials support

Australia should adopt a “mission” to develop its research and manufacturing capabilities around RNA (ribonucleic acid) and its potential for technologies, a national working group has said.

RNA is a naturally occurring genetic material with a growing list of technological applications. For example, one form of RNA provided the basis for Covid-19 vaccines developed by pharmaceutical companies including BioNTech and Moderna.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.